Your shopping cart is currently empty

6'-Sialyllactose (6'-SL) is one of the most predominant human milk oligosaccharides (HMOs) with significant prebiotic activity, promoting the growth of beneficial bacteria (e.g., Bifidobacterium and Lactobacillus) while inhibiting harmful pathogens. 6'-SL exhibits pleiotropic biological activities: it diminishes stress-induced anxiety via the gut-brain axis, ameliorates benign prostatic hyperplasia by suppressing VEGF-mediated angiogenesis (via Akt-ERK inhibition), and enhances exercise performance by increasing muscle mass and strength. It also reduces the internalization of Pseudomonas aeruginosa in human pneumocytes.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $48 | Inquiry | Inquiry | |
| 5 mg | $123 | Inquiry | Inquiry | |
| 10 mg | $197 | Inquiry | Inquiry | |
| 25 mg | $332 | Inquiry | Inquiry | |
| 50 mg | $496 | Inquiry | Inquiry | |
| 100 mg | $693 | Inquiry | Inquiry |
| Description | 6'-Sialyllactose (6'-SL) is one of the most predominant human milk oligosaccharides (HMOs) with significant prebiotic activity, promoting the growth of beneficial bacteria (e.g., Bifidobacterium and Lactobacillus) while inhibiting harmful pathogens. 6'-SL exhibits pleiotropic biological activities: it diminishes stress-induced anxiety via the gut-brain axis, ameliorates benign prostatic hyperplasia by suppressing VEGF-mediated angiogenesis (via Akt-ERK inhibition), and enhances exercise performance by increasing muscle mass and strength. It also reduces the internalization of Pseudomonas aeruginosa in human pneumocytes. |
| In vitro | 6'-Sialyllactose (0–50 μM, 24 h) inhibits DHT-induced HUVEC proliferation and tube formation by downregulating p-Akt/p-ERK and blocking VEGFR-2 signaling. It also reduces Pseudomonas aeruginosa internalization in human pneumocyte models [1][4]. |
| In vivo | In vivo, supplementing mouse diets with 5% 6'-Sialyllactose for 2 weeks significantly diminishes stressor-induced anxiety-like behavior and maintains the number of DCX-positive cells in the hippocampus [2]. In muscle health studies, oral administration of 6'-SL (100 mg/kg, 12 weeks) increases muscle mass and strength, leading to improved exercise endurance [3]. Furthermore, it effectively ameliorates benign prostatic hyperplasia in mice by suppressing angiogenesis [4] |
| Molecular Weight | 633.55 |
| Formula | C23H39NO19 |
| Cas No. | 35890-39-2 |
| Smiles | O(C[C@H]1O[C@@H](O[C@@H]([C@@H]([C@H](C=O)O)O)[C@@H](CO)O)[C@H](O)[C@@H](O)[C@H]1O)[C@@]2(C(O)=O)O[C@@]([C@@H]([C@@H](CO)O)O)([C@H](NC(C)=O)[C@@H](O)C2)[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.